United States Digital Medicine Market Driven by Rising Proliferation of Mobile Devices in Healthcare Industry


Published Date : May 23, 2016

ALBANY, New York, May 23, 2016: A recent market research report featured on MarketResearchReports.biz presents an in-depth overview of the present scenario of the U.S. digital medicine market and predicts the market’s developmental prospects through the period 2016-2020. The report is titled “The United States Digital Medicine Market: Size, Trends & Forecasts (2016-2020).”

Various health-related concerns surrounding diseases, disorders, and syndromes are rising worldwide. These in turn increase need for the effective management and reports of patient data for the early detection and prevention of these health issues. Researchers and scientists are trying to devise ways of accommodating the use of advanced technologies and the ubiquitous mobile computing devices. This has given rise to the market for digital health. Digital medicine is a subsidiary of the digital health market and deals specifically with the concept of analyzing patient health data and prescribing customized medications.

Digital medicine practices involve prescribing either a combination of drugs and therapeutic treatments or simply digital therapeutic treatments. Such practices provide patients and their respective healthcare teams with real time healthcare data for effective treatment even at remote locations.

Numerous factors are driving the U.S. digital medicine market, including the rapid proliferation of smartphones in the healthcare industry, the flourishing software industry, rising healthcare expenditures, increased investments in the biopharma industry, rising population, and the rising prevalence of several chronic diseases in the country.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/717514

However, there are several challenges that are holding back the market to a certain extent, including limited functionality of digital medicine mobile applications, substantial time and capital investments required for the implementation of digital medicine setup, lack of clinical evidence, and certain regulatory hurdles.

The report analyzes the U.S. digital medicine market from the perspective of market value, key market segments, and clinical trial sponsors. It also examines the market based on the categories of healthcare applications.

An analytical overview of the major growth opportunities in the U.S. digital medicine market has also been included in the report, complete with insights into the various factors that are driving the market. The impact of these factors on the overall developmental prospects of the U.S. digital medicine market over the period 2016-2020 has also been analyzed and explained in ways that make the complex market data easy for comprehension.

The report also presents a detailed overview of the competitive scenario of the U.S. digital medicine market, which despite being at its nascent state of development features intense competition. The market is fragmented and has many small companies. Some of the companies profiled in the report are Ginger.io, Inc., Akili Interactive Labs, Inc., Mocacare, Livongo, Omada Health, Inc., WellDoc, Inc., Glooko, Inc., Omada Health, Inc., AliveCor, Inc., Voluntis, etc., 2morrow, Inc.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz